ACM
FENC icon

AIGH Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

AIGH Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
1,981,501
+400,000
+25% +$3.09M 1.66% 18
2025
Q4 		$12.2M Buy
1,581,501
+900,000
+132% +$7.39M 2.95% 12
2025
Q3 		$6.38M Buy
681,501
+229,101
+51% +$1.98M 1.8% 20
2025
Q2 		$3.75M Buy
452,400
+91,395
+25% +$625K 1.69% 22
2025
Q1 		$2.2M Buy
+361,005
New +$2.32M 0.91% 30
2024
Q2 		– Sell
-570,332
Closed -$6.34M – 43
2024
Q1 		$6.34M Buy
570,332
+240,962
+73% +$2.42M 1.9% 13
2023
Q4 		$3.7M Sell
329,370
-44,156
-12% -$366K 1.46% 27
2023
Q3 		$2.81M Buy
373,526
+24,069
+7% +$196K 1.33% 22
2023
Q2 		$3.09M Buy
349,457
+187,303
+116% +$1.56M 1.26% 21
2023
Q1 		$1.35M Buy
+162,154
New +$1.5M 0.5% 40

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIGH Capital Management's FENC Position: Q1 2026 in Review

AIGH Capital Management increased its Fennec Pharmaceuticals (FENC) stake by 25% in Q1 2026, buying an estimated $3.09M and bringing the position to 1,981,501 shares worth $12.2M. The position accounts for 1.66% of the portfolio, ranked #18.

AIGH Capital Management first reported a position in FENC in Q1 2023 and has held it in 10 quarters since. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • AIGH Capital Management held 1,981,501 shares of Fennec Pharmaceuticals worth $12.2M as of Q1 2026.
  • AIGH Capital Management bought 400,000 Fennec Pharmaceuticals shares in Q1 2026, an estimated $3.09M.
  • Fennec Pharmaceuticals made up 1.66% of AIGH Capital Management's portfolio in Q1 2026, its #18 holding.
  • AIGH Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 10 quarters since.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.